- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-28-0042013

Segmed Pharmaceuticals Private Limited
About Segmed Pharmaceuticals Private Limited
Data last updated:
Segmed Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 27 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33112UP2020PTC126192.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shailendra Kumar Dwivedi and Neeraj Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 2002 Arihant Ambar Greater Noida, Uttar Pradesh, India – 201308.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.4 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹4,307 (net margin 0.8%) and EBITDA of ₹5,820 (EBITDA margin 1.1%).
Segmed Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0042013).
Company details
Recognitions & Rankings of Segmed Pharmaceuticals
Contact details
Segmed Pharmaceuticals Private Limited's registered office is in Uttar Pradesh.
- Registered AddressA – 2002 Arihant Ambar Greater Noida, Uttar Pradesh, India – 201308
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing, Medical & Surgical Equipment, Orthopedic Appliances, Surgical, Dental Instrument Manufacturing, Medical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Segmed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Segmed Pharmaceuticals Private Limited, buy the company report.
Financials of Segmed Pharmaceuticals Private Limited
FY 2024 filings availableSegmed Pharmaceuticals Private Limited reported revenue of ₹5.4 Lakh (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year. EBITDA fell 11% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,820 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,307 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Segmed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Segmed Pharmaceuticals Private Limited
Segmed Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailendra Kumar Dwivedi | Director | 27 Jan 2020 | 6 Years 9 Months | Current |
| Neeraj Srivastava | Director | 27 Jan 2020 | 6 Years 9 Months | Current |
| Pawan Kumar Singh | Director | 27 Jan 2020 | 6 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Segmed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Segmed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Segmed Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Segmed Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Neeraj Srivastava was appointed as Director on 27 Jan 2020.
Frequently asked questions
Segmed Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 27 January 2020 (6+ years old) and is registered under CIN U33112UP2020PTC126192.
Segmed Pharmaceuticals has 3 current directors:
- Shailendra Kumar Dwivedi - Director
- Neeraj Srivastava - Director
- Pawan Kumar Singh - Director
The latest financial statements of Segmed Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Segmed Pharmaceuticals is U33112UP2020PTC126192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Segmed Pharmaceuticals was incorporated on 27 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Neeraj Srivastava was appointed as Director on 27 Jan 2020. Pawan Kumar Singh was appointed as Director on 27 Jan 2020. Shailendra Kumar Dwivedi was appointed as Director on 27 Jan 2020.
Yes, Segmed Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0042013).
The registered office of Segmed Pharmaceuticals is at A – 2002 Arihant Ambar Greater Noida, Uttar Pradesh, India – 201308.
Segmed Pharmaceuticals operates in the healthcare industry, in the medical appliances and instruments segment.
Segmed Pharmaceuticals can be reached at its registered office: A – 2002 Arihant Ambar Greater Noida, Uttar Pradesh, India – 201308.

